Projects per year
- 1 - 50 out of 272 results
Search results
-
Finished
Imaging of Osteonecrosis of the Femoral Head
Alsaker, B. (Leader)
12/1/21 → 2/1/22
Project: Research project
-
Moving Human Papillomavirus (HPV) Self-Sampling into Primary Care Clinics: A Pre-Implementation Study to Address Cervical Cancer Screening Inequities in Minnesota
Xiong, S. (Collaborator)
9/1/20 → 8/1/21
Project: Internal Grant
-
A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction of 40%
Alexy, T. (PI)
BAYER HEALTHCARE PHARMACEUTICALS
7/1/20 → 7/31/24
Project: Research project
-
A Phase 2, Randomized, Double-Blind, Placebo-Controlled,Parallel-Group, Multicenter, Dose Escalation and Proof-of-ConceptStudy to Evaluate the Safety and Efficacy of Razuprotafib inHospitalized Subjects With Moderate to Severe Coronavirus Disease
Pritzker, M. R. (PI)
7/1/20 → 7/31/24
Project: Research project
-
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SAFETY, TOLERABILITY, AND EFFICACY OF RV521 IN THE TREATMENT OF ADULT SUBJECTS WHO HAVE UNDERGONE HEMATOPOIETIC CELL TRANSPLANTATION (HCT) WITH A DOCUMENTED UPPER RESPIRATORY TRACTINFECTION (URT)
Young, J.-A. H. (PI)
6/24/20 → 1/31/24
Project: Research project
-
Assessment of day to day variation of a novel fecal Calprotectin assay in patients with UC
Vaughn, B. P. (PI) & Campbell, J. P. (CoI)
5/21/20 → 12/31/23
Project: Research project
-
FT516-102:APhase I, Open-Label, Multicenter Study of FT516 in Combination with Monoclonal Antibodies in Subjectswith Advanced Solid Tumors
Patel, M. R. (PI)
2/20/20 → 3/1/23
Project: Research project
-
A Phase 2, Multi-Center, Open-Label Study to Evaluate Long-term Safety and Efficacy of CXA-10 in Subjects with Pulmonary Arterial Hypertension on Stable Background Therapy: Extension to Study CXA-10-301 (Complexa CXA-10-2302 - PRIMEx Open Label Extension
Prins, K. W. (PI)
2/1/20 → 2/28/23
Project: Research project
-
A Study to Characterize the Genetic, Biomarker, and Clinical Profile of Patients with Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)
Zand, L. (PI)
12/12/19 → 9/30/20
Project: Research project
-
A PHASE 1, OPEN-LABEL, MULTI-CENTER, DOSE ESCALATION AND DOSEEXPANSION STUDY OF NKTR-255 AS A SINGLE AGENT IN RELAPSED OR REFRACTORYHEMATOLOGICAL MALIGNANCIES AND IN COMBINATION WITH DARATUMUMAB AS A SALVAGEREGIMEN FOR MULTIPLE MYELOMA
Bachanova, V. (PI) & Janakiram, M. (Prior Principal Investigator)
12/2/19 → 12/31/24
Project: Research project
-
ExtraVascular Implantable Cardioverter Defibrillator(EV ICD) Pivotal Study
Roukoz, H. (PI)
10/1/19 → 7/31/24
Project: Research project
-
A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium(Clostridioides) Difficile Infection
Young, J.-A. H. (PI)
8/22/19 → 8/30/24
Project: Research project
-
A Phase 2 Randomized, Dose-blind, Multicenter Study to Evaluate the Safety and Efficacy of KZR-616 in the Treatment of Patients with Autoimmune Hemolytic Anemia and Immune Thrombocytopenia
Vercellotti, G. M. (PI) & Mazepa, M. (Prior Principal Investigator)
8/20/19 → 9/1/20
Project: Research project
-
Phase 3 Study of Sacituzumab Govitecan (IMMU-132) Versus Treatment of Physician's Choice (TPC) in subjects with Hormonal Receptor-Positive (HR+) Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer (MBC) who have failed at le
Potter, D. A. (PI)
8/19/19 → 8/31/24
Project: Research project
-
A Phase 1/2a Open-label Study to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-573 (formerly TEV-48573) Administered Intravenously as a Single Agent in Patients With Refractory Multiple Myeloma
Janakiram, M. (PI)
8/14/19 → 8/30/24
Project: Research project
-
MMP-01: Pilot Study Evaluating Activity of the Combination of Anti-PD-1 Antibody with High Dose IL-2 in Metastatic Melanoma
Domingo-Musibay, E. (PI)
HOOSIER CANCER RESEARCH NETWORK, INC
8/12/19 → 12/31/19
Project: Research project
-
ES-301: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
Peterson, E. J. (PI)
8/2/19 → 8/30/24
Project: Research project
-
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Clinical Outcomes, Antiviral Activity, Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics/Pharmacodynamics of JNJ-53718678 in Adult and Adolescent Hematopoietic Stem Cell Tran
Young, J.-A. H. (PI)
JANSSEN RESEARCH & DEVELOPMENT, LLC
7/31/19 → 7/31/24
Project: Research project
-
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)
Shmidt, E. (PI)
7/18/19 → 6/30/20
Project: Research project
-
Transfemoral Replacement of Aortic Valve with HLT MeriDIAN Valve CE Mark Trial
Raveendran, G. (PI)
HEART LEAFLET TECHNOLOGIES, INC
7/1/19 → 7/31/23
Project: Research project
-
FT-004: Long-term Follow-Up Study Following Treatment with Fate Therapeutics Cellular Immunotherapy
Brunstein, C. G. (PI)
6/26/19 → 2/23/21
Project: Research project
-
A Phase 2 Study of ALKS 4230 in Combination With Anti-PD-1 (Pembrolizumab) in Patients With Advancedor Recurrent Head and Neck Squamous Cell Cancer Currently on Treatment With Anti-PD-(L)1 WithoutHaving Achieved a Complete Remission
Patel, M. R. (PI)
FRED HUTCHINSON CANCER CENTER, ALKERMES, INC
5/31/19 → 5/31/24
Project: Research project
-
FT516-101: A Phase I Study of FT516 as Monotherapy in Relapsed/Refractory Acute Myelogenous Leukemia and in Combination with Monoclonal Antibodies in Relapsed/Refractory B-Cell Lymphoma
Brunstein, C. G. (PI)
5/28/19 → 5/31/24
Project: Research project
-
FT-003: Long-term, Non-interventional, Observation Study Post Fate Therapeutics' Cellular Immunotherapy
Patel, M. R. (PI)
5/20/19 → 5/31/24
Project: Research project
-
A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy ofStereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab (MK-3475) in Participants withMedically Inoperable Stages I or IIA Non Small Cell Lung C
Patel, M. R. (PI)
5/2/19 → 5/31/24
Project: Research project
-
MT2018-36 INSPIRE: A Multicenter Randomized Controlled Trial integrating health informatics in a scalablestepped care self-management program for survivors after hematopoietic cell transplantation
Holtan, S. G. (PI)
FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)
5/1/19 → 4/30/20
Project: Research project
-
An Open-Label, Phase 4 Study to Evaluate the Efficacy and Safety of Triple Combination Therapy With Vedolizumab IV, Adalimumab SC, and Oral Methotrexate in Early Treatment of Subjects With Crohn's Disease Stratified at Higher Risk for Developing Complica
Shmidt, E. (PI)
TAKEDA DEVELOPMENT CENTER AMERICAS, INC.
5/1/19 → 5/31/24
Project: Research project
-
iELEVATE (Improving womEn's and chiLdren's hEalth Via biobanking and elecTronic rEgistry)
Eder, M. (PI)
THE UNIVERSITY OF IOWA, NATIONAL INSTITUTES OF HEALTH (NIH)
3/13/19 → 2/28/22
Project: Research project
-
A phase II, open-label study of ONC201 in adults with recurrent high-grade glioma
Chen, C. C. (PI)
3/12/19 → 3/30/24
Project: Research project
-
Protocol ATI001-102 Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Combination with Nivolumabin Subjects with Recurrent or Progressive Glioblastoma
Chen, C. C. (PI)
2/21/19 → 2/28/23
Project: Research project
-
Phase I/II pharmacokinetic multi-tumor study of subcutaneous formulation of nivolumab monotherapy
Domingo-Musibay, E. (PI)
2/1/19 → 1/30/20
Project: Research project
-
Protocol Writing, Review, IRB submission for: A Phase I/II Trial in Patients with Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in which the Gene Encoding CISH was Inactivated Using the CRISPR/ Cas9 System
Lou, E. (PI)
2/1/19 → 8/1/20
Project: Research project
-
MT2018-07 A Multi-Center Phase 2 Study of Combined Modality Treatment with Ruxolitinib, Decitabine, and Donor Lymphocyte Infusion for Post-Transplant Relapse of AML or MDS
Juckett, M. B. (PI) & Rashidi, A. (Prior Principal Investigator)
1/31/19 → 9/30/24
Project: Research project